1. Електронний репозитарій ДВНЗ "УжНУ"

Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 71 (Search time: 0.003 seconds).
Item hits:
Issue DateTitleAuthor(s)
1993Прогресс в лечении остеогенной саркомыГотько, Євген Степанович; Трапезников Н. Н.; Соловьев Ю. Н.; Еремина Л. А; Амирасланов А. Т.; Феденко А. Н.; Синюков П. А.; Григорова Т, М.; Токарева З. И.; Ковалевський Е. Е.
2014-02Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation statusГотько, Євген Степанович; Shikha Gaur; Linling Chen; Vincent Ann; Wei-Chen Lin; Yafan Wang; Vincent HS Chang; Her-Shuyong Shia; Nan Yong Hsu; Yun Yen
2016-10-20Maintenance erlotinib versus erlotinib at disease progression inpatients with advanced non-small-cell lung cancer who have notprogressed following platinum-based chemotherapy (IUNO study)Готько, Євген Степанович; Saulius Cicènas; Sarayut Lucien; Geater Petar Petrov; Gregory Hooper; Fan Xia; Nadejda Mudie; Yi-Long Wu
2013A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the PAVES StudyГотько, Євген Степанович; Tamás Pintera; Zandra Klippel; Alvydas Cesas; Adina Croitoru; Jochen Decaestecker; Peter Gibbs; Jacek Jassem; Galina Kurteva; Jan Novotny; Seamus O’Reilly; Tomas Salek; Maureen Reiner
2012Final results from study 181: Randomized phase III study of FOLFIRI with or without panitumumab (pmab) for the treatment of second-line metastatic colorectal cancer (mCRC)Готько, Євген Степанович; Alberto F. Sobrero; Marc Peeters; Timothy Jay Price; Andres Cervantes-Ruiperez; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Ying Tian; Roger Sidhu
2016Peculiarities of breast cancer incidence rate in urban population and implementation of screening programs in health care systemГотько, Євген Степанович; Svyatoslav V Zhero; Dmytro Y Tsyhyka; Victor Y Ihnatko; Natalia Y Pohorelova
2009-03Etude de phase III (20050181) de l’association panitumumab + 5-fluorouracile, acide folinique, irinotecan (Folfiri) versus Folfiri seul en seconde ligne de traitement des cancers colorectaux métastasés. Analyse poolée de toxicitéГотько, Євген Степанович; M. Ducreux; G. Wilson; A. Cervantès; T. André; F. Lordick; S. Collins; M. Shing; T. Price; M. Peeters
2015Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)Готько, Євген Степанович; T. Pinter P.K. Morrow A. Cesas A. Croitoru J. Decaestecker P. Gibbs; J. Jassem G. Kurteva J. Novotny S. O'Reilly T. Salek L. Khosrowshahi M. Reiner Z. Klippel C. Blanke
2015Analysis of KRAS/NRAS Mutations in a Phase 3 Study of Panitumumab With FOLFIRI Compared With FOLFIRI Alone as Second-Line Treatment for Metastatic Colorectal CancerГотько, Євген Степанович; Marc Peeters; Kelly S. Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Cornelis J. A. Punt; Andrew Strickland
2013Resultsof a phase III, randomized, double-blind, placebocontrolledtrialofpegfilgrastim (PEG) inpatients (pts) receivingfirst-line FOLFOX or FOLFIRI andbevacizumab (B) forcolorectalcancer (CRC)Готько, Євген Степанович; Tamas Pinter; Esteban Abella; Alvydas Cesas; Adina Croitoru; Jochen Decaestecker; Peter Gibbs; Jacek Jassem; Galina Petrova Kurteva; Jan Novotny; Seamus O'Reilly; Tomas Salek; May F. Mo

Discover